Status:
RECRUITING
Argentine Registry of Crohn's Disease and Ulcerative Colitis
Lead Sponsor:
Grupo Argentino de Enfermedad de Crohn y Colitis Ulcerosa
Conditions:
Epidemiology
Inflammatory Bowel Disease (IBD)
Eligibility:
All Genders
Brief Summary
RADECCU is a strictly observational IBD registry in Argentina. The registry is open to all practicing gastroenterologist in the country grouped within the Argentinean Crohn's and Ulcerative Colitis Gr...
Detailed Description
Aims: The primary objective of the registry is to create an IBD physicians' network in Argentina that captures pragmatic and relevant information from IBD patients in terms of demographic, clinical a...
Eligibility Criteria
Inclusion
- Any patient diagnosed with IBD defined by validated diagnostic criteria can be included into the registry. The criteria for IBD diagnosis were based on previously published criteria for IBD diagnosis, including clinical, endoscopic, laboratory, and histopathological aspects, as well as small bowel imaging studies
Exclusion
- Suspected IBD diagnosis without confirmation
- IBD patients with incomplete information about therapy and follow-up
Key Trial Info
Start Date :
July 14 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2027
Estimated Enrollment :
4250 Patients enrolled
Trial Details
Trial ID
NCT07155148
Start Date
July 14 2023
End Date
December 30 2027
Last Update
September 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Privado Universitario de Cordoba
Córdoba, Córdoba Province, Argentina, 5016